Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis
- PMID: 20159642
- DOI: 10.1016/j.jcmg.2009.09.023
Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis
Abstract
Objectives: Our aim was to evaluate the role and mechanism of late gadolinium enhancement (LGE) cardiac magnetic resonance (CMR) in identifying cardiac amyloidosis (CA) and to investigate associations between LGE and clinical, morphologic, functional, and biochemical features.
Background: CA can be challenging to diagnose by echocardiography. Recent studies have demonstrated an emerging role for LGE-CMR.
Methods: LGE-CMR was performed in 120 patients with amyloidosis. Cardiac histology was available in 35 patients. The remaining 85 patients were divided into those with and without echocardiographic evidence of CA.
Results: Of the 35 patients with histologically verified CA, abnormal LGE was present in 34 (97%) patients and increased echocardiographic left ventricular wall thickness in 32 (91%) patients. Global transmural or subendocardial LGE (83%) was most common and was associated with greater interstitial amyloid deposition (p = 0.03). Suboptimal myocardial nulling (8%) and patchy focal LGE (6%) were also observed. LGE distribution matched the deposition pattern of interstitial amyloid. Among patients without cardiac histology, LGE was present in 86% of those with evidence of CA by echocardiography and in 47% of those without evidence of CA by echocardiography. In patients without echocardiographic evidence of CA, the presence of LGE was associated with worse clinical, electrocardiographic (ECG), and cardiac biomarker profiles. In all patients, LGE presence and pattern was associated with New York Heart Association functional class, ECG voltage, left ventricular mass index, right ventricular wall thickness, troponin-T, and B-type natriuretic peptide levels.
Conclusions: LGE is common in CA and detects interstitial expansion from amyloid deposition. Global transmural or subendocardial LGE is most common, but suboptimal myocardial nulling and focal patchy LGE are also observed. LGE-CMR may detect early cardiac abnormalities in patients with amyloidosis with normal left ventricular thickness. The presence and pattern of LGE is strongly associated with clinical, morphologic, functional, and biochemical markers of prognosis.
2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Comment in
-
MR Imaging and Cardiac Amyloidosis Where to Go From Here?JACC Cardiovasc Imaging. 2010 Feb;3(2):165-7. doi: 10.1016/j.jcmg.2009.10.013. JACC Cardiovasc Imaging. 2010. PMID: 20159643 No abstract available.
Similar articles
-
LGE Provides Incremental Prognostic Information Over Serum Biomarkers in AL Cardiac Amyloidosis.JACC Cardiovasc Imaging. 2016 Jun;9(6):680-6. doi: 10.1016/j.jcmg.2015.10.027. Epub 2016 May 18. JACC Cardiovasc Imaging. 2016. PMID: 27209101
-
The diagnostic performance of cardiac magnetic resonance in detection of myocardial involvement in AL amyloidosis.Clin Physiol Funct Imaging. 2016 May;36(3):218-24. doi: 10.1111/cpf.12216. Epub 2014 Nov 13. Clin Physiol Funct Imaging. 2016. PMID: 25393773
-
Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics.J Cardiovasc Magn Reson. 2017 Aug 7;19(1):61. doi: 10.1186/s12968-017-0376-0. J Cardiovasc Magn Reson. 2017. PMID: 28784140 Free PMC article.
-
Prognostic Value of Late Gadolinium Enhancement CMR in Systemic Amyloidosis.JACC Cardiovasc Imaging. 2016 Nov;9(11):1267-1277. doi: 10.1016/j.jcmg.2016.01.036. Epub 2016 Aug 24. JACC Cardiovasc Imaging. 2016. PMID: 27568115 Review.
-
Cardiac amyloidosis: in search of the ideal diagnostic tool.Herz. 2021 Apr;46(Suppl 1):9-14. doi: 10.1007/s00059-019-04871-5. Epub 2019 Dec 3. Herz. 2021. PMID: 31796976 Review. English.
Cited by
-
Cardiac amyloidosis and aortic stenosis: a state-of-the-art review.Eur Heart J Open. 2023 Oct 12;3(6):oead106. doi: 10.1093/ehjopen/oead106. eCollection 2023 Nov. Eur Heart J Open. 2023. PMID: 37941729 Free PMC article. Review.
-
Cardiac imaging in patients with chronic kidney disease.Nat Rev Nephrol. 2015 Apr;11(4):207-20. doi: 10.1038/nrneph.2014.243. Epub 2015 Jan 6. Nat Rev Nephrol. 2015. PMID: 25561081 Review.
-
Sudden death in lambda light chain AL cardiac amyloidosis: a review of literature and update for clinicians and pathologists.Int J Clin Exp Pathol. 2020 Jul 1;13(7):1474-1482. eCollection 2020. Int J Clin Exp Pathol. 2020. PMID: 32782665 Free PMC article. Review.
-
How to Identify Transthyretin Cardiac Amyloidosis at an Early Stage.Intern Med. 2021 Jan 1;60(1):1-7. doi: 10.2169/internalmedicine.5505-20. Epub 2020 Jul 21. Intern Med. 2021. PMID: 32713926 Free PMC article. Review.
-
Clinical Utility and Future Applications of PET/CT and PET/CMR in Cardiology.Diagnostics (Basel). 2016 Sep 2;6(3):32. doi: 10.3390/diagnostics6030032. Diagnostics (Basel). 2016. PMID: 27598207 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical